Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2023 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Donna Holder
Donna Holder is the Senior Director, Global MSL Excellence at Daiichi Sankyo Inc (DSI) where she is accountable for ensuring the strategic alignment of MSL activities across DSI regions, and for strengthening the MSL capability worldwide. Donna has over 25 years of experience in the pharmaceutical industry with a wealth of experience in Medical Affairs. Most recently she was the Executive Director, Global Field Medical Center of Excellence (CoE) at Merck from January 2018 to May 2020 where she was responsible for the Field Medical capability worldwide along with the leadership of scientific and capability training function for Field Medical.
She started her career at Marion Merrell Dow (now Sanofi) in Clinical Development and then joined AstraMerck (now AstraZeneca Pharmaceuticals) where she spent over ten years in senior leadership roles including leadership of MSL, Medical Information, and Contact Center teams. In her last role at AZ as Senior Director, MSL Excellence in Global Medical Affairs, Donna was accountable for the strategic direction of the MSL function. She led development, delivery, and measurement of initiatives to strengthen MSL capabilities worldwide. Donna left AZ at the end of 2014 and became a Medical Affairs consultant, partnering with pharmaceutical and biotech clients to deliver solutions including capability development, business process development, business strategy, operations management, and coaching. Donna earned her Doctor of Pharmacy from the University of Michigan.
Renu Juneja
Renu Juneja is Head of Scientific Evidence and Communications at Janssen Biotechnology Inc (JBI). Her team has the responsibility for publication plans, medical education, medical booth content, KOL engagements, MSL slide decks & training, cooperative studies and clinical trial operations in Oncology Medical affairs at JBI. Before joining Janssen, Renu was head of the Medical Communications group at MedImmune (the worldwide biologics research and development arm of AstraZeneca). Her group had the responsibility for both regulatory documents and development & execution of strategic publication plans. Her team supported all therapeutic areas including Immuno-oncology, respiratory, inflammation, CVMD, infectious diseases and vaccines.
Previously, she led the Strategic Scientific Communication (SSC) group at Novo Nordisk Inc. (NNI). She also had the opportunity to lead the Information & Education group at NNI and was responsible for the company’s library and for Independent Medical Education (IMEs) programs. Renu started her career in Novo Nordisk as a medical writer. After finishing her PhD in Reproductive Biology & Biochemistry from the Post-Graduate Institute of Medical Education & Research (PGIMER) in India, Renu joined The Population Council in NY as a Postdoctoral fellow. Two years later, she received an independent research grant from the Lalor Foundation and joined the department of Molecular Biology at the Princeton University. She has over 30 publications in peer-reviewed journals and has presented at various national and international conferences.
Renu has presented and conducted workshops at the annual meetings of various professional organizations e.g. ISMPP, TIPPA, CBI, and Q1 productions.
Arron Mungul
Arron joined Bristol-Myers Squibb (BMS) in 2015 in the Global Medical Affairs team, where he was the Market Interface Lead, supporting the implementation of local strategy and launches across oncology. Currently, Arron is part of the Medical Capabilities group, leading an international team responsible for the medical content supporting the execution of local medical affairs plans in Europe and Canada for the entire BMS portfolio.
Prior to BMS, Arron was a Senior Scientific Director in Global Medical Affairs at GSK Oncology and Novartis Oncology, responsible for scientific strategy and communications across several brands. He has also worked in medical communications agencies in London and Switzerland.
Arron received his degree in Biochemistry from Imperial College, London, and his PhD from the Imperial Cancer Research Fund/Cancer Research UK for his work in breast cancer.